TAMPA, Fla. – Sila Realty Trust, Inc. (the “Company”), a net lease real estate investment trust focused on investing in high quality healthcare properties across the continuum of care, today announced the acquisition of a 25,150 square foot medical office building located in West Palm Beach, Florida (the “West Palm Beach Healthcare Facility”) for approximately $9.85 million.
The West Palm Beach Healthcare Facility is a fully leased two-story building with the majority being occupied by OB/GYN Specialists of the Palm Beaches (“OB/GYN Specialists”), which specializes in high-risk pregnancies and births. OB/GYN Specialists offers comprehensive obstetrical and gynecologic services, with specific services at the West Palm Beach Healthcare Facility including general practice, perinatology and urogynecology.
OB/GYN Specialists has a total of 35 board-certified physicians with six of seven locations throughout the West Palm Beach-Boca Raton-Delray Beach, Florida Metropolitan Statistical Area (MSA). OB/GYN Specialists is part of the Unified Women’s Healthcare network. Unified Women’s Healthcare is the largest physician practice management company solely dedicated to women, with a network including over 2,600 providers at over 925 care centers and 36 fertility clinics nationwide.
“We are pleased to be partnering with OB/GYN Specialists which is widely recognized as a premier OB/GYN practice in the area,” stated Michael A. Seton, President and Chief Executive Officer of the Company. “The West Palm Beach Healthcare Facility is strategically located within the heart of an established and thriving medical district. This acquisition aligns with our proven strategy to grow our medical office building portfolio and geographic footprint through regional physician affiliations.”
About Sila Realty Trust, Inc.
Sila Realty Trust, Inc. is a public, non-traded net lease real estate investment trust headquartered in Tampa, Florida, that invests in high quality healthcare properties leased to tenants capitalizing on critical and structural economic growth drivers. The Company is focused on investing in and managing strategic healthcare assets across the continuum of care, with emphasis on lower cost patient settings, which generate predictable, durable, and growing income streams. As of March 31, 2023, the company owned 131 healthcare properties and two undeveloped land parcels located in 58 markets across the United States.
Certain statements contained herein, other than historical fact, may be considered “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, and are intended to be covered by the safe harbor provided by the same. These statements are based on management’s current expectations and beliefs and are subject to a number of trends and uncertainties. No forward-looking statement is intended to, nor shall it, serve as a guarantee of future performance. You can identify the forward-looking statements by the use of words such as “anticipate,” “believe,” “continue,” “could,” “estimate,” “expect,” “intend,” “may,” “outlook,” “plan,” “potential,” “predict,” “project,” “seek,” “should,” “will” and other similar terms and phrases, including references to the Company’s growth strategies. Forward-looking statements are subject to various risks and uncertainties and factors that could cause actual results to differ materially from the Company’s expectations, and you should not rely on forward-looking statements since they involve known and unknown risks, uncertainties and other factors, which are, in some cases, beyond the Company’s control and could materially affect the Company’s results of operations, financial condition, cash flows, performance or future achievements or events. Additional factors include those described under the section entitled Item 1A. “Risk Factors” of Part I of the Company’s 2022 Annual Report on Form 10-K with the SEC, copies of which are available at www.sec.gov. The Company undertakes no obligation to publicly update or revise any forward-looking statement, whether as a result of new information, future events, or otherwise, except as required by law.